Anuja Jhingran, M.D., FASTRO, FACR

Peer-Reviewed Articles

1. Anakwenze Akinfenwa CP, Ibraheem A, Nwankwo K, Lasebikan N, Ali-Gombe M, Aliyu UM, Ikhile E, Adegboyega O, Abdullahi A, Klopp AH, Schmeler K, Lin LL, Jhingran A, Page BR, Leng J, Grover S, Ntekim A. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria. JCO Glob Oncol 7:1260-1269, 2021. PMID: 34351813.
2. Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys 109(2):413-424, 2021. e-Pub 2020. PMID: 32905846.
3. Li BC, Chew J, Wakefield DV, Agarwal A, Jhingran A. Frameworks for Radiation Oncology Global Health Initiatives in US Residency Programs. JCO Glob Oncol 7:233-241, 2021. PMID: 33570998.
4. Salvo G, Ramalingam P, Flores Legarreta A, Jhingran A, Gonzales NR, Chisholm GB, Frumovitz M. Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study. Int J Gynecol Cancer. e-Pub 2021. PMID: 33563641.
5. Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
6. El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
7. Harkenrider MM, Markham MJ, Dizon DS, Jhingran A, Salani R, Serour RK, Lynn J, Kohn EC. Moving Forward in Cervical Cancer - Enhancing Susceptibility to DNA Repair Inhibition and Damage: NCI Clinical Trials Planning Meeting Report. J Natl Cancer Inst 112(11):1081-1088, 2020. e-Pub 2020. PMID: 32219419.
8. Expert Panel on GYN and OB Imaging, Reinhold C, Ueno Y, Akin EA, Bhosale PR, Dudiak KM, Jhingran A, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, Paspulati R, Shinagare AB, Small W, Vargas HA, Whitcomb BP, Glanc P. ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer. J Am Coll Radiol 17(11S):S472-S486, 2020. PMID: 33153558.
9. Rhee DJ, Jhingran A, Kisling K, Cardenas C, Simonds H, Court L. Automated Radiation Treatment Planning for Cervical Cancer. Semin Radiat Oncol 30(4):340-347, 2020. PMID: 32828389.
10. Stecklein SR, Taniguchi CM, Melancon AD, Lombe D, Lishimpi K, Banda L, Mwaba C, Pupwe G, Mwale M, Munkupa H, Kanduza M, Mule B, Mwale A, Court L, Ohrt JD, Kupferman ME, Jhingran A, Msadabwe-Chikuni SC. Radiation Sciences Education in Africa: An Assessment of Current Training Practices and Evaluation of a High-Yield Course in Radiation Biology and Radiation Physics. JCO Glob Oncol 6:1631-1638, 2020. PMID: 33108232.
11. Small W, Peltecu G, Puiu A, Corha A, Cocîr?a E, Cigaran RG, Plante M, Jhingran A, Stang K, Gaffney D, Bacon M, McCormack M. Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference. Int J Gynecol Cancer. e-Pub 2020. PMID: 33122244.
12. Scanderbeg DJ, Yashar C, Ouhib Z, Jhingran A, Einck J. Development, implementation, and associated challenges of a new HDR brachytherapy program. Brachytherapy. e-Pub 2020. PMID: 32950407.
13. Rhee DJ, Jhingran A, Rigaud B, Netherton T, Cardenas CE, Zhang L, Vedam S, Kry S, Brock KK, Shaw W, O'Reilly F, Parkes J, Burger H, Fakie N, Trauernicht C, Simonds H, Court LE. Automatic contouring system for cervical cancer using convolutional neural networks. Med Phys. e-Pub 2020. PMID: 32964477.
14. Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer 126(11):2607-2613, 2020. e-Pub 2020. PMID: 32125711.
15. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W, Yashar CM, Viswanathan AN. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecol Oncol. e-Pub 2020. PMID: 32563593.
16. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
17. Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, Jhingran A, Pareja R. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer 30(5):561-563, 2020. e-Pub 2020. PMID: 32221023.
18. Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
19. Sapienza LG, Ning MS, de la Pena R, McNew LK, Jhingran A, Georgeon L, Rasool N, Gomes MJL, Abu-Isa E, Baiocchi G. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. Int J Gynecol Cancer. e-Pub 2020. PMID: 32376738.
20. Kisling K, Cardenas C, Anderson BM, Zhang J, Jhingran A, Simonds H, Balter P, Howell RM, Schmeler K, Beadle BM, Court L. Automatic verification of beam apertures for cervical cancer radiotherapy. Pract Radiat Oncol. e-Pub 2020. PMID: 32450365.
21. Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecol Oncol. e-Pub 2020. PMID: 32475772.
22. Lin LL, Lakomy DS, Ning MS, Simpkins F, Jhingran A. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Int J Gynecol Cancer 30(4):409-423, 2020. e-Pub 2020. PMID: 32193219.
23. Armbruster SD, Fellman BM, Jhingran A, Eifel PJ, Klopp AH, Coleman RL, Ramondetta LM, Frumovitz M. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. e-Pub 2020. PMID: 32338316.
24. Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G. Pelvic insufficiency fractures after external beam radiotherapy for gynecologic cancers: a meta-analysis and meta-regression of 3,929 patients. Int J Radiat Oncol Biol Phys 106(3):475-484, 2020. e-Pub 2019. PMID: 31580930.
25. Colbert LE, Jhingran A. Immunotherapy and Radiation. Adv Exp Med Biol 1244:205-213, 2020. PMID: 32301016.
26. Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy. e-Pub 2019. PMID: 31786169.
27. Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. e-Pub 2019. PMID: 31500892.
28. Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. Gynecol Oncol 154(2):328-332, 2019. e-Pub 2019. PMID: 31221496.
29. Damast S, Jeffery DD, Son CH, Hasan Y, Carter J, Lindau ST, Jhingran A. Literature Review of Vaginal Stenosis and Dilator Use in Radiation Oncology. Pract Radiat Oncol. e-Pub 2019. PMID: 31302301.
30. Kassab C, Ramirez PT, Jhingran A, Bhosale P, Broaddus R. Endometrial cancer with cervical extension in an obese patient: options for surgery versus combined chemoradiotherapy and extra-fascial hysterectomy. Int J Gynecol Cancer 29(5):976-980, 2019. PMID: 31155519.
31. Kisling K, Zhang L, Yang J, Balter PA, Howell RM, Court L, Shaitelman SF, Jhingran A, Anderson D, Thebe T, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM. Automated treatment planning of postmastectomy radiotherapy. Med Phys. e-Pub 2019. PMID: 31077593.
32. Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol. e-Pub 2019. PMID: 31109659.
33. Vorbeck CS, Jhingran A, Iyer RB, Loft A, Klopp A, Mirza MR, Sobremonte A, Vedam S, Vogelius IR. Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer. Int J Gynecol Cancer. e-Pub 2019. PMID: 31126968.
34. Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy. e-Pub 2019. PMID: 31160198.
35. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy. e-Pub 2019. PMID: 30992185.
36. Kisling K, Johnson JL, Simonds H, Zhang L, Jhingran A, Beadle BM, Burger H, Toit MD, Joubert N, Makufa R, Shaw W, Trauernicht C, Balter P, Howell RM, Schmeler K, Court L. A Risk Assessment of Automated Treatment Planning and Recommendations for Clinical Deployment. Med Phys. e-Pub 2019. PMID: 31002389.
37. Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol 135:58-64. e-Pub 2019. PMID: 31015171.
38. Salcedo MP, Sood AK, Dos Reis R, Ramalingam P, Chen C, Frumovitz M, Jhingran A, Pitcher B, Ramirez PT, Schmeler KM. Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. Gynecol Oncol 152(1):101-105, 2019. e-Pub 2018. PMID: 30396690.
39. Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol 14:40-46, 2019. e-Pub 2018. PMID: 30555940.
40. Kisling K, Zhang L, Simonds H, Fakie N, Yang J, McCarroll R, Balter P, Burger H, Bogler O, Howell R, Schmeler K, Mejia M, Beadle BM, Jhingran A, Court L. Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics. J Glob Oncol(2019):1-9, 2019. PMID: 30629457.
41. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet 393(10167):169-182, 2019. PMID: 30638582.
42. Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis. Gynecol Oncol 151(3):573-578, 2018. e-Pub 2018. PMID: 30333082.
43. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
44. Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W. Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. Int J Radiat Oncol Biol Phys 101(5):1069-1077, 2018. e-Pub 2018. PMID: 29885996.
45. Ager BJ, Gallardo-Rincón D, de León DC, Chávez-Blanco A, Chuang L, Dueñas-González A, Gómez-García E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Pérez-Plasencia C, Plante M, Poveda A, Gaffney DK. Advancing Clinical Research Globally: Cervical Cancer Research Network from Mexico. Gynecol Oncol Rep 25:90-93, 2018. e-Pub 2018. PMID: 30014021.
46. Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD. Society of Gynecologic Oncology Future of Physician Payment Reform Task Force Report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecol Oncol 149(2):232-240, 2018. e-Pub 2018. PMID: 29544708.
47. Expert Panel on Women’s Imaging:, Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande PV, Salazar GM, Shipp TD, Simpson L, Small W, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P. ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer. J Am Coll Radiol 15(5S):S198-S207, 2018. PMID: 29724422.
48. Court LE, Kisling K, McCarroll R, Zhang L, Yang J, Simonds H, du Toit M, Trauernicht C, Burger H, Parkes J, Mejia M, Bojador M, Balter P, Branco D, Steinmann A, Baltz G, Gay S, Anderson B, Cardenas C, Jhingran A, Shaitelman S, Bogler O, Schmeller K, Followill D, Howell R, Nelson C, Peterson C, Beadle B. Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System. J Vis Exp(134), 2018. e-Pub 2018. PMID: 29708544.
49. Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132-138, 2018. e-Pub 2017. PMID: 29089122.
50. Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy 16(6):1129-1143, 2017. e-Pub 2017. PMID: 28888417.
51. McCarroll R, Youssef B, Beadle B, Bojador M, Cardan R, Famiglietti R, Followill D, Ibbott G, Jhingran A, Trauernicht C, Balter P, Court L. Model for Estimating Power and Downtime Effects on Teletherapy Units in Low-Resource Settings. J Glob Oncol 3(5):563-571, 2017. e-Pub 2017. PMID: 29094096.
52. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. e-Pub 2017. PMID: 28930812.
53. Small W, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK. Cervical cancer: A global health crisis. Cancer 123(13):2404-2412, 2017. e-Pub 2017. PMID: 28464289.
54. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol 7(3):e165-e173, 2017. e-Pub 2016. PMID: 27743802.
55. Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys 97(3):546-553, 2017. e-Pub 2016. PMID: 28011045.
56. Grover S, Xu M, Jhingran A, Mahantshetty U, Chuang L, Small W, Gaffney D. Clinical trials in low and middle-income countries - Successes and challenges. Gynecol Oncol Rep 19:5-9, 2017. e-Pub 2016. PMID: 28004030.
57. Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol 143(3):552-557, 2016. e-Pub 2016. PMID: 27645621.
58. Gaffney D, Small B, Kitchener H, Young Ryu S, Viswanathan A, Trimble T, Covens A, Wilailak S, Lertkhachonsuk AA, Sitathanee C, Mahantshetty U, Fisher B, Springer S, Pollatz T, Spiller A, Bacon M, Jhingran A. Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale. Int J Gynecol Cancer 26(9):1690-1693, 2016. PMID: 27779548.
59. Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 96(4):793-800, 2016. e-Pub 2016. PMID: 27788952.
60. Elshaikh MA, Vance S, Gaffney DK, Biagioli M, Jhingran A, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W, Expert Panel on Radiation Oncology–Gynecology:. ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer. Am J Clin Oncol 39(5):507-15, 2016. PMID: 27400117.
61. Wahl AO, Gaffney DK, Jhingran A, Yashar CM, Biagioli M, Elshaikh MA, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Williams NL, Small W. ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer. Oncology (Williston Park) 30(9):816-22, 2016. PMID: 27633412.
62. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys 95(4):1191-200, 2016. e-Pub 2016. PMID: 27130794.
63. Jhingran A, Klopp A. Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer?. Gynecol Oncol 141(3):403-4, 2016. PMID: 27210265.
64. Kisling K, Zhang L, Yang J, Jhingran A, Balter P, McCarroll R, Beadle B, Howell R, Schmeler K, Court L. SU-F-T-423: Automating Treatment Planning for Cervical Cancer in Low- and Middle- Income Countries. Med Phys 43(6):3560, 2016. PMID: 28048573.
65. Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, Merritt DF, Park JE, Siston A, Straub M, Streicher L. Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist. CA Cancer J Clin 66(3):241-63, 2016. e-Pub 2016. PMID: 26784536.
66. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-based Peer-review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract 12(4):e476-86, 2016. e-Pub 2016. PMID: 26931402.
67. Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chávez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W, Gynecologic Cancer InterGroup Cervix Cancer brainstorming day. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Int J Gynecol Cancer 26(1):199-207, 2016. e-Pub 2015. PMID: 26569057.
68. Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, FMerritt DF, Park JE, Siston A, Straub M, Streicher L. Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation wiht a specialist. CA Cancer J Clin, 2016. e-Pub 2016.
69. Jones E, Beriwal S, Beyer D, Chino J, Jhingran A, Lee L, Michalski J, Mundt AJ, Patton C, Petersen I, Portelance L, Schwarz JK, McCloskey S. An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary. Adv Radiat Oncol 1(1):26-34, 2016. e-Pub 2015. PMID: 28799571.
70. Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol 5(6):e557-65, 2015. e-Pub 2015. PMID: 26432679.
71. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W. ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park) 29(11):867-72, 874-5, 2015. PMID: 26568534.
72. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol 139(1):40-6, 2015. e-Pub 2015. PMID: 26193429.
73. Cox M, Carmack C, Hughes D, Baum G, Brown J, Jhingran A, Lu K, Basen-Engquist K. Antecedents and mediators of physical activity in endometrial cancer survivors: Increasing physical activity through steps to health. Health Psychol 34(10):1022-32, 2015. e-Pub 2015. PMID: 25642840.
74. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer 121(13):2156-63, 2015. e-Pub 2015. PMID: 25847373.
75. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy. Int J Gynecol Cancer 25(5):869-74, 2015. e-Pub 2015. PMID: 25790043.
76. Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 14(3):385-9, 2015. e-Pub 2015. PMID: 25620163.
77. Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM. High-grade cervical dysplasia following radiation therapy for invasive cervical cancer: A report of four cases. Case Rep Oncol 8(2):217-21, 2015. e-Pub 2015. PMID: 26078740.
78. Gómez-Hidalgo NR, Darin MC, Dalton H, Jhingran A, Fleming N, Brown J, Ramirez PT. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol 22(4):687-90, 2015. e-Pub 2015. PMID: 25772021.
79. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?. Gynecol Oncol 136(2):269-73, 2015. e-Pub 2014. PMID: 25524458.
80. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr. ACR Appropriateness Criteria Adjuvant Therapy in Vulvar Cancer. Oncology 29(11):867-875, 2015.
81. Jeffery DD, Barbera L, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014. J Psychosoc Oncol 33(4):433-66, 2015. PMID: 25997102.
82. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 2014. PMID: 25415160.
83. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 90(2):320-8, 2014. PMID: 25304792.
84. Martinez W, Thaker N, Jhingran A, Kuban DA. A radiation oncology peer review program for community hospitals. J Clin Oncol 32(30_suppl):200, 2014. PMID: 28141415.
85. Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W, Varia MA, Wahl AO, Yuh W, Gaffney DK, Expert Panel on Radiation Oncology-Gynecology:. ACR appropriateness Criteria® advanced stage endometrial cancer. Am J Clin Oncol 37(4):391-6, 2014. PMID: 24977691.
86. Sun C, Brown AJ, Jhingran A, Frumovitz M, Ramondetta L, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer 24(6):1077-84, 2014. PMID: 24905618.
87. Abu-Rustum N, Chi D, Coleman RL, del Campo JM, Fotopoulou C, Frumovitz M, Gershenson DM, Gonzalez A, Jhingran A, Ledermann J, Mariani A, Mirza M, Oaknin A, Ramirez PT, Schmeler KM, Sood AK. Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol 134(1):6-9, 2014. PMID: 24952408.
88. Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W. Radiation Therapy Oncology Group Gynecologic Oncology Working Group: Comprehensive Results. Int J Gynecol Cancer 24(5):956-62, 2014. e-Pub 2014. PMID: 24819663.
89. Basen-Engquist K, Carmack C, Brown J, Jhingran A, Baum G, Song J, Scruggs S, Swartz MC, Cox MG, Lu KH. Response to an exercise intervention after endometrial cancer: Differences between obese and non-obese survivors. Gynecol Oncol 133(1):48-55, 2014. PMID: 24680591.
90. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. Int J Radiat Oncol Biol Phys 88(2):357-62, 2014. PMID: 24411609.
91. Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, Macapinlac HA, Leblanc E, Martinez A, Ramirez PT. Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): A phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol 21(1):3-8, 2014. e-Pub 2013. PMID: 23911560.
92. Small W, Bosch WR, Strauss JB, Albuquerque K, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles TW, Jhingran A, Klopp AH, Kunos C, Mell LK, Powell M, Viswanathan AN, Yashar CM, Gaffney D. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer - an update. Int J Radiat Oncol Biol Phys 90(S1):S109, 2014.
93. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol 131(3):645-9, 2013. e-Pub 2013. PMID: 23643871.
94. Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK. ACR appropriateness criteria management of vaginal cancer. Oncology (Williston Park) 27(11):1166-73, 2013. PMID: 24575547.
95. Likhacheva A, Jhingran A, Bodurka DC, Sun C, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly Cisplatin or every-3-week Cisplatin and 5-Fluorouracil. Int J Gynecol Cancer 23(8):1520-1527, 2013. PMID: 24257567.
96. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-Field Radiation Therapy for Locoregionally Recurrent Ovarian Cancer. Gynecol Oncol 130(2):300-305, 2013. e-Pub 2013. PMID: 23648467.
97. Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR, Expert Panel on Radiation Oncology-Gynecology:. ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva. Am J Clin Oncol 36(4):415-422, 2013. PMID: 23872794.
98. Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol 129(2):304-9, 2013. e-Pub 2013. PMID: 23385150.
99. Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D'Souza D, Souhami L, Small W, Gaur R, Jhingran A. Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer. Int J Radiat Oncol Biol Phys 86(1):83-90, 2013. PMID: 23582248.
100. Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer 23(4):615-21, 2013. PMID: 23552804.
101. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, 2013. e-Pub 2012. PMID: 24674314.
102. Wagner A, Jhingran A, Gaffney D. Intensity Modulated Radiotherapy in Gynecologic Cancers: Hope, Hype or Hyperbole?. Gynecol Oncol. e-Pub 2013. PMID: 23632209.
103. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys 85(4):1045-50, 2013. e-Pub 2013. PMID: 23332221.
104. Fontanilla HP; Kelly P; Jhingran A, Iyer RB, Levenback C, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of FDG-avid paraaortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. e-Pub 2013.
105. Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM. COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and Celecoxib: A quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer 23(1):176-183, 2013. PMID: 23221733.
106. Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G [Jhingran A] on behalf of the participants of the second GCIG Endometrial Cancer Clinical Trials Planning Meeting. Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era. Int J Gynecol Ca 23(8):1528-1534, 2013.
107. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol 3(1):45-53, 2013. e-Pub 2012. PMID: 24674263.
108. Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3(1):e21-8, 2013. e-Pub 2012. PMID: 24674269.
109. Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W, Berk L, Gaffney D. A phase II study of intensity-modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418. Int J Radiat Oncol Biol Phys 84(1):e23-8, 2012. e-Pub 2012. PMID: 22543211.
110. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: Implications for surgical staging. Int J Gynecol Cancer 22(7):1203-7, 2012. e-Pub 2012. PMID: 22810967.
111. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-7, 2012. e-Pub 2011. PMID: 21640510.
112. Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM. Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. e-Pub 2012. PMID: 22483697.
113. Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 82(1):256-62, 2012. e-Pub 2010. PMID: 21093170.
114. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Reports 2:9-10, 2012.
115. Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK.. ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. Am J Clin Oncol 35(4):399-405, 2012. PMID: 22810416.
116. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P, American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy 11(1):53-7, 2012. PMID: 22265438.
117. Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small, Jr. W, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. International Journal of Gynecological Cancer. e-Pub 2011. PMID: 22155418.
118. Fisher CM, Fortenberry BR, Jhingran A, Eifel PJ. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol 1(3):152-155, 2011. e-Pub 2011. PMID: 24673944.
119. Sharp HJ, Pinnix CC, Jhingran A, Euscher ED, Rohren EM, Ramirez PT. PET/CT in a patient with adenoma malignum of the uterine cervix. Clin Nucl Med 36(6):468-469, 2011. PMID: 21552028.
120. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: A prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 117(9):1928-1934, 2011. e-Pub 2010. PMID: 21509770.
121. Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR. ACR Appropriateness Criteria® on advanced cervical cancer expert panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys. e-Pub 2011. PMID: 21215531.
122. Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM; and Expert Panel on Women's Imaging and Radiation Oncology-Gynecology. ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q 27(2):139-145, 2011. PMID: 21606818.
123. Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of RTOG 0116. Int J Gynecol Ca 21(7):1266-1275, 2011. e-Pub 2011. PMID: 21892091.
124. Faro JP, Graybill WS, Tung CS, Jhingran A, Ramirez PT, Schmeler KM. Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report. Gynecol Oncol Case Rep 2(1):9-10, 2011. e-Pub 2011. PMID: 24371600.
125. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor Kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 78(5):1331-6, 2010. e-Pub 2010. PMID: 20231067.
126. Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 2010. e-Pub 2010. PMID: 20837355.
127. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De Los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium.. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. e-Pub 2010. PMID: 20472347.
128. Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 76(5):1396-403, 2010. e-Pub 2009. PMID: 19581056.
129. Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
130. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 2009. e-Pub 2009. PMID: 19632709.
131. Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JA. Evaluation of intervention to prevent hypomagnesaemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer 17(9):1195-201, 2009. e-Pub 2009. PMID: 19172305.
132. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: Does marital status matter?. Int J Gynecol Cancer 19(6):1107-12, 2009. PMID: 19820377.
133. Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney D. Changes in gene expression predicting local control in cervix cancer: Results from RTOG 0128. Clin Cancer Res 15(12):4199-4206, 2009. e-Pub 2009. PMID: 19509178.
134. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-8, 2009. e-Pub 2008. PMID: 19110220.
135. Beadle BM, Jhingran A, Salehpour M, Sam M, Iyer RB, Eifel PJ. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73(1):235-41, 2009. e-Pub 2008. PMID: 18513882.
136. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 19(1):2-7, 2009. PMID: 19258933.
137. Kitchener HC, Trimble EL, Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup. Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1):134-140, 2009. PMID: 19258955.
138. Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 112(4):899-905, 2008. PMID: 18827134.
139. Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial cancer. Int J Radiat Oncol Biol Phys 71(2):428-434, 2008. e-Pub 2007. PMID: 18037584.
140. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-36, 2008. PMID: 18406887.
141. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478-481, 2008. e-Pub 2008. PMID: 18190952.
142. Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1):118-25, 2008. e-Pub 2007. PMID: 17869451.
143. Ramondetta LM, Jhingran A. Eleven years: The long and winding road. Gynecol Oncol 107(2):166-168, 2007. PMID: 17950382.
144. Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68(4):1081-1087, 2007. e-Pub 2007. PMID: 17398031.
145. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-479, 2007. e-Pub 2007. PMID: 17292459.
146. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan RJ, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W, Soper J, Teng N, National Comprehensive Cancer Network. Uterine cancers. J Natl Compr Canc Netw 4(5):438-62, 2006. PMID: 16687093.
147. Eifel PJ, Jhingran A, Brown J, Levenback C, Thames H. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 16(3):1106-11, 2006. PMID: 16803493.
148. Iyer R, Jhingran A. Radiation injury: Imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging 31(6):S131-9, 2006. e-Pub 2006. PMID: 17114067.
149. Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol 103(2):547-53, 2006. e-Pub 2006. PMID: 16730784.
150. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, Jhingran A, Levenback C. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol 15(2):79-83, 2006. e-Pub 2006. PMID: 17035002.
151. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-13, 2005. e-Pub 2005. PMID: 16169678.
152. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: A Monte Carlo study. Phys Med Biol 50(21):5075-87, 2005. e-Pub 2005. PMID: 16237242.
153. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 2005. PMID: 16234510.
154. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 2005. PMID: 16168853.
155. Solin LJ, Fourquet A, Vicini FA, Taylor M, Haffty B, Strom EA, Wai E, Pierce LJ, Marks LB, Bartelink H, Campana F, McNeese MD, Jhingran A, Olivotto IA, Bijker N, Hwang WT. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 41(12):1715-23, 2005. PMID: 16043350.
156. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117-24, 2005. PMID: 15990017.
157. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138-47, 2005. PMID: 15850914.
158. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 2005. PMID: 15850913.
159. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61(4):1062-1070, 2005. PMID: 15752885.
160. Solin LJ, Fourquet A, Vicini FA, Taylor M, Olivotto IA, Haffty B, Strom EA, Pierce LJ, Marks LB, Bartelink H, McNeese MD, Jhingran A, Wai E, Bijker N, Campana F, Hwang WT. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6):1137-46, 2005. PMID: 15674853.
161. Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Heterogeneity of stage IIIA endometrial carcinomas: Implications for adjuvant therapy. Int J Gynecol Cancer 15(3):510-6, 2005. PMID: 15882178.
162. Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MT. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer 15(4):646-56, 2005. PMID: 16014119.
163. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93(1):27-33, 2004. PMID: 15047210.
164. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786-96, 2004. PMID: 14967435.
165. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 91(3):463-9, 2003. PMID: 14675663.
166. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, Jhingran A, Eifel P, Montz F, Wharton JT. Innovations in the treatment of invasive cervical cancer. Cancer 98(Suppl 9):2052-2063, 2003. PMID: 14603542.
167. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57(2):409-18, 2003. PMID: 12957252.
168. Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 90(3):625-8, 2003. PMID: 13678736.
169. Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecol Oncol 90(3):529-36, 2003. PMID: 13678720.
170. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56(5):1366-72, 2003. PMID: 12873682.
171. Kabbani W, Deavers MT, Malpica A, Burke TW, Liu J, Ordoñez NG, Jhingran A, Silva EG. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol 22(3):297-302, 2003. PMID: 12819400.
172. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J 9(1):33-41, 2003. PMID: 12602766.
173. Jhingran A, Kim JS, Buchholz TA, Katz A, Strom EA, Hunt KK, Sneige N, McNeese MD. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 54(3):804-9, 2002. PMID: 12377332.
174. Munkarah AR, Jhingran A, Iyer RB, Wallace S, Eifel PJ, Gershenson D, Burke TW. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer 12(6):755-9, 2002. PMID: 12445255.
175. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 2002. PMID: 12202666.
176. Iyer RB, Jhingran A, Sawaf H, Libshitz HI. Imaging findings after radiotherapy to the pelvis. AJR Am J Roentgenol 177(5):1083-9, 2001. PMID: 11641175.
177. Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18(15):2817-27, 2000. PMID: 10920129.
178. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 46(5):1177-83, 2000. PMID: 10725629.
179. Verstovsek S, Verschraegen CF, Edwards CL, Malpica A, Kavanagh JJ, Ross MI, Strom EA, Jhingran A, Theriault RL, Kudelka AP. Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference]. Am J Clin Oncol 23(1):99-103, 2000. PMID: 10683089.
180. Buchholz TA, Tucker SL, Moore RA, McNeese MD, Strom EA, Jhingrin A, Hortobagyi GN, Singletary SE, Champlin RE. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. Int J Radiat Oncol Biol Phys 46(2):337-343, 2000. PMID: 10661340.
181. Hogberg T, Fredstorp M, Jhingran A. Indications for adjuvant radiotherapy in endometrial carcinoma. Hematol Oncol Clin North Am 13(1):189-209, 1999. PMID: 10080076.

Invited Articles

1. Jeffery DD, BarberaL, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE. Self-reported sexual function measures administered to female cancer patients: A systemic review 2008-2014. Journal of Psychosocial Oncology, 2015.
2. Frumovitz M, Jhingran A, Schmeler KM. Early-stage cervical cancer: Treatment choices vary according to disease stage and patient-specific factors. OncoLog 57(7), 2012.
3. Bhosale P, Iyer R, Jhingran A, Podoloff D. PET/CT imaging in gynecologic malignancies other than ovarian and cervical cancer. PET Clin 5(4):463-475, 2010. e-Pub 2010. PMID: 27157973.
4. Jhingran A. Technical advances in radiation oncology for the treatment of cervical carcinoma. Revista de Ginecologia Oncologica 3:18-26, 2008.
5. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol 16(3):144-51, 2006. PMID: 16814154.
6. Jhingran A. The Shivnani/Rimel/Schink/Small article reviewed: Cancer of the cervix: Current management and new approaches. Oncology 20(12):3, 2006.
7. Ahamad A, Jhingran A. New radiation techniques in gynecological cancer. Int J Gynecol Cancer 14(4):569-79, 2004. PMID: 15304149.

Manuals, Teaching Aids, Other Teaching Publications

1. Monk BJ, Coleman RL, Herzog TJ, Jhingran A, Wright TC. Cases in Advanced Gynecological Cancers: A Virtual Tumor Board, Meniscus Educational Institute Website, 2005.

Editorials

1. Jhingran A. Is team management appropriate for a patient receiving coronary brachytherapy?. Int J Radiat Oncol Biol Phys 57(1):3, 2003. PMID: 12909206.

Abstracts

1. Takiar V, Burks JK, Sulman EP, Ramondetta LM, Jhingran A, Deavers MT, Eifel PJ, Klopp AH. PD-1 levels correlate with lymph node positivity in patients with squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 90(S1):S479, 2014.
2. Swanick CW, Castle KO, Cunningham MG, Vedam S, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Impact of normal tissue motion on dose to critical structures during intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 90(S1):S482, 2014.
3. Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Factors associated with long-term survival in locally-advanced squamous cell carcinoma of the vulva treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013.
4. Thaker N, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with pelvic lymph node-positive stage IVB vulvar cancer: Time to reconsider the FIGO staging system?. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013.
5. Klopp AH, Jhingran A, Juloori A, Perinjelil V, Broaddus R, Lu K, Eifel PJ. Management of Node-positive endometrial cancer with multimodality adjuvant therapy. Int J Radiat Oncol Biol Phys 84(3S):S455, 2012.
6. Hashem R, Winter K, Ruo R, Portelance L, Jhingran A, Demas W, Jacobson GM, Gaffney D. Defining the impact of the use of oral contrast in pelvic intensity modulated radiation therapy (IMRT) – an RTOG 0418 secondary analysis. Int J Radiat Oncol Biol Phys 84(3S):S18, 2012.
7. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally confined ovarian cancer. Int J Radiat Oncol Biol Phys 84(3S):S96, 2012.
8. Juloori A, Klopp A, Ramondetta L, Jhingran A, Euscher E, Fleming N, Lu KJ, Eifel PJ. Radiation therapy in the management of carcinosarcoma of the uterus. Int J Radiat Oncol Biol Phys 84(3S):S456, 2012.
9. Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Definitive radiation therapy of locally advanced squamous cell carcinoma of the vulva: Factors associated with vulvar disease control. Int J Radiat Oncol Biol Phys 84(3S):S460, 2012.
10. Jhingran A, Winter K, Portelance L, Miller BE, Salehpour MR, Gaur R, Souhami L, Small W, Gaffney D. Efficacy and safety of IMRT after surgery in patients with endometrial cancer: RTOG 0418 phase II study. Int J Radiat Oncol Biol Phys 81(2, Suppl):S45, 2011.
11. Portelance L, Moughan J, Jhingran A, Miller BE, Salehpour MR, D'Souza D, Haddock M, Rotman M, Gaffney DK. A phase II multi-institutional study of postoperative pelvic intensity modulated radiation therapy (IMRT) with weekly cisplatin in patients with cervical carcinoma: Two year efficacy results of the RTOG 0418. Int J Radiat Oncol Biol Phys 81(2, Suppl):S3, 2011.
12. Fontanilla HP, Klopp AH, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Distribution of para-aortic lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S187, 2011.
13. Shirvani SM, Klopp AH, Jhingran A, Lu KH, Soliman PT, Eifel PJ. Intensity modulated radiotherapy for definitive treatment of para-aortic relapse in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S190, 2011.
14. Klopp AH, Jhingran A, Pardeshi V, Schmeler K, Bodurka D, Lu K, Eifel PJ. Chemoradiation therapy followed by adjuvant chemotherapy for management of stage IIIC2 endometrial cancer. Int J Radiat Oncol Biol Phys 81(2, Suppl):S191, 2011.
15. Verma J, Klopp AH, Jhingran A, Hildebrandt E, Tucker S, Eifel PJ. Dosimetric predictors of duodenal toxicity following IMRT to para-aortic nodes. Int J Radiat Oncol Biol Phys 81(2, Suppl):S473, 2011.
16. Fisher CM, Klopp AH, Jhingran A, Vera R, Levenback C, Eifel PJ. Vaginal cancer outcomes using intensity modulated radiation therapy for definitive treatment at UT MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys 81(2, Suppl):S480, 2011.
17. Patel H, Klopp AH, Jhingran A, Lindberg ME, Iyer RB, Kelly P, Zhang Y, Dong L, Eifel PJ. Mapping location of PET positive lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 78(3):S143, 2010.
18. Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Diaz R, Magliocco AM. Low COX-2 expression, but not CD34, predicts for worse overall survival in patients with locally-advanced cervical cancer treated with chemoradiotherapy and celecoxib: A comparative immunohistochemical analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 75(3):S150, 2009.
19. Klopp AH, Jhingran A, Eifel PJ, Deavers MT, Sulman EP. Galectin-7 is a prognostic factor for radiation response in squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 75(3):S365, 2009.
20. Sulman EP, Eifel PJ, Jhingran A, Aldape KD, Deavers MT, Klopp AH. Podoplanin expression is prognostic for survival of patients with squamous cell carcinoma of the cervix treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 75(3):S370, 2009.
21. Schmeler K, Jhingran A, Iyer R, Sun C, Eifel P, Soliman P, Ramirez P, Frumovitz M, Bodurka D, Sood A.. Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors. Proceedings of the 2008 Annual Meeting for the Felix Rutledge Society, 2008, 2008.
22. Jhingran A, Winter K, Portelance L, Miller BE, Salehpour M, Gaur R, Souhami L, Small W, Berk LB, Gaffney D. A phase II study of intensity modulated radiation therapy (IMRT) to the pelvic for post-operative patients with endometrial carcinoma (RTOG 0418). Int J Rad Oncol Biol Phys 72(1, Suppl):S16, 2008.
23. Weidhaas JB, Li S, Winter K, Ryu J, Jhingran A, Miller B, Dicker A, Gaffney D. Changes in gene expression predicting local control in cervical cancer: Results from RTOG 0128. Int J Radiat Oncol Biol Phys 72(1, Suppl):S16, 2008.
24. Small W, Winter K, Levenback C, Iyer R, Hymes S, Jhingran A, Gaffney D, Erickson B, Greven K.. Extended field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of Arm 2 of RTOG 0116. Int J Radiat Oncol Biol Phys 69(3):S5, 2007.
25. Eifel P, Levenback C, Jhingran A, Thames H. Predictive Value of a Proposed Subclassification of Stage I and II Cervical Cancer Using Clinical Tumor Diameter. Gyn Oncol 101(1, Suppl 1):S181, 2006.
26. Eifel PJ, Klopp A, Ramondetta LM, Gershenson DM, Jhingran A. Node-positive Adenocarcinoma of the Endometrium: Outcome and Patterns of Recurrence. Int J Radiat Oncol Biol Phys 66(3):S166, 2006.
27. Beadle BM, Jhingran A, Salehpour M, Sam M, Eifel PJ. Tumor Regression and Organ Motion During the Course of Chemoradiation for Cervical Cancer: Implications for Treatment Planning and Use of IMRT. Int J Radiat Oncol Biol Phys 66(3):S44, 2006.
28. Eifel PJ, Jhingran AColeman R, Thames HD. Is Anemia a Cause of Radiation Treatment Failure in Patients With Squamous Carcinoma of the Cervix?. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S94, 2005.
29. Jhingran A. Concurrent Chemoradiation in the Routine Management of Patients With Cervical Cancer: How Does the Experience Compare With Treatment on a Prospective Randomized Trial?. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S95, 2005.
30. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary Adenocarcinoma of the Vagina. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S215, 2005.
31. Jhingran A, Yom SS, Zang X, Eifel PJ. Recurrence Above the Radiotherapy Field After Definitive Treatment of Cervix Cancer. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S217, 2005.
32. Gaffney DK, Winter K, Dikcer A, Miller B, Jhingran A, Ryu J, Avizonis V, Fromm M, Greven K. A phase I-II study of COX-2 inhibitor, Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 63(2, Suppl 1):S93-94, 2005.
33. Jhingran A. A Pilot Study to Evaluate Consistency of Bladder Filling and Vaginal Movement in Patients Receiving Pelvic IMRT. Proceedings of the 87th Annual Meeting of the American Radium Society, 2005.
34. Price M, Gifford K, Horton J, Eifel P, Lawyer A, Jhingran A, and Mourtada F. Comparison of LDR to PDR Dose Distributions: A Monte Carlo Study. Medical Physics 32(6):2098, 2005.
35. Mell L, Fyles A, Small W, Creutzberg C, Jhingran A, Arcangeli G, Varia M, Hatano K, De Los Santos J, Barillot I, Roeske J, Mundt A. Adjuvant intensity modulated pelvic radiation therapy in gynecologic malignancies: Survey of the gynecologic IMRT working group. Int J Radiat Oncol Biol Phys 60(1):S215-6, 2004.
36. Jhingran A, Levenback C, Katz A, Eifel PJ. Radiation therapy for vulvar carcinoma: predictors of vulvar recurrence. Int J Radiat Oncol Biol Phys 57(2):S193, 2003.
37. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive treatment of vaginal cancer with radiation therapy. Int J Radiat Oncol Biol Phys 57(2):S194, 2003.
38. Pelloski CE, Palmer MB, Chronowski GM, Horton JL, Jhingran A, Eifel PJ. CT-based volumetric dosimetry of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 57(2):S343-4, 2003.
39. Strom E, Solin LJ, Vicini FA, Taylor ME, Olivotto IA, Haffty BG, Pierce LJ, Marks LB, Jhingran A, Wai ES, Bijker N, Harry B. Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 57(2):S240-1, 2003.
40. Gifford KA, Lawyer AA, Jhingran A, Eifel PJ, Horton JL. Monte Carlo calculations around a commercial gynecological applicator. AAPM 2003 Annual Meeting, San Diego Medical Physics, 30(8):1470, 2003.
41. Viswanathan A, Jhingran A, Deavers M, Ramirez P, Eifel PJ. Patterns of failure in small cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54(2):41, 2002.
42. Ahamad A, Souza WD, Salehpour M, Iyer R, Thames H, Jhingran A, Eifel PJ. Intensity modulated radiation therapy (IMRT) for post-hysterectomy pelvic radiation: Selection of patients and planning target volume (PTV). Int J Radiat Oncol Biol Phys 54(2):42-43, 2002.
43. Woodward WA, Katz A, Buchholz T, McNeese M, Perkins G, Jhingran A, Strom E. Patterns and predicators of locoregional recurrence in 469 patients treated with post-mastectomy radiation. Int J Radiat Oncol Biol Phys 54(2, Suppl 1):92, 2002.
44. Callister M, Jhingran A, Ramondetta L, Burke T, Eifel PJ. Malignant mixed millerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 51(Suppl 1):37-38, 2001.
45. Katz A, Eifel PJ, Jhingran A, Levenback C. Radiotherapy results in excellent regional control for patients with squamous cell carcinoma (SCC) of the vulva. Int J Radiat Oncol Biol Phys 5(3, Suppl 1):38, 2001.
46. Jhingran A, Wiatrek R, Levenback C, Eifel PJ. Late complications of postoperative radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 51(3, Supp 1):216, 2001.
47. Eifel PJ, Jhingran A, Atkinson HN, Bodurka-Bevers D. The influence of smoking history and other patient characteristics on the risk of major complications after radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 48(3, Suppl 1):212, 2000.
48. Katz A, Strom EA, Buchholz TA, Jhingran A, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 48(3, Suppl 1):141-142, 2000.
49. Fossella FV, Zinner RG, Komaki R, Jung M, Jhingran A, Glisson BS, Pisters KM, Stevens CW, Khuri FR, Kurie JM, et al.. Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with Gemcitabine plus Cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC). Lung Cancer 29(1, Suppl 1):111-112, 2000.
50. Zinner R, Fossella FV, Komaki R, Delclos M, Jung M, Glisson BS, Lee JS, Pisters K, Jhingran A, Hong WK. Phase I trial of concurrent gemcitabine (G) plus chest radiotherapy (XRT), followed by consolidation systemic chemotherapy with G plus cisplatin (CDDP), for patients with stage III and medically inoperable stage II non-small cell lung cancer (NSCLC). J Clin Oncol (ASCO 35th Annual Meeting) 18:466a, 1999.
51. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 42(5):151, 1998. PMID: 10725629.

Book Chapters

1. Burke TW, Jhingran A, Lu K, and Broaddus R. Endometrial Cancer. In: 60 years of survival outcomes at the University of Texas MD Anderson Cancer Center. Springer: New York, 109-117, 2013.
2. Jhingran A, Shaaban AM. Ovary and Fallopian Tube. In: Radiation Oncology Imaging and Treatment. 1st. Amirsys Publishing, Inc: Canada, 54-75, 2013.
3. Jhingran A, Russell AH, Seiden MV, Duska LR, Goodman AK, Lee SI, Digumarthy SR, Fuller Jr AF. Cancers of the cervix, Vulva, and Vagina. In: Clinical Oncology. 5th. Elsevier Churchill Livingstone: Philadelphia, PA, 1534-1574, 2013.
4. Klopp A, Jhingran A. Field cancerization in vulvar, vaginal, and cervical epithelia. In: Field Cancerization: Basic Science and Clinical Applications. Nova Science Publishers, Inc: New York, 415-421, 2011.
5. Jhingran A, Eifel PJ. The endometrium. In: Radiation Oncology. 9th. Mosby: St. Louis, MO, 774-797, 2010.
6. Jhingran A. The ovary. In: Radiation Oncology. 9th. Mosby: St. Louis, MO, 812-832, 2010.
7. Jhingran A. Neoplasms of the cervix. In: Cancer Medicine. 8th. People's Medical Publishing House - USA: Shelton, CT, 1299-1324, 2010.
8. Jhingran A, Eifel PJ. Radiation therapy for cervical carcinoma. In: Gynecology & Obstetrics. Global Library of Women's Medicine, 2008.
9. Jhingran A. Predictors of radiation sensitivity and resistance. In: Prognostic and Predictive Factors in Gynecologic Cancer. Taylor & Francis Medical Books: United Kingdom, 259-267, 2007.
10. Jhingran A, Levenback C. Malignant diseases of the cervix. In: Comprehensive Gynecology. 5th. Mosby: Philadelphia,PA, 759-780, 2007.
11. Jhingran A, Eifel PJ, Ramirez PT. Treatment of locally advanced cervical cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag: New York, 102-124, 2006.
12. Ramondetta LM, Bodurka DC, Deavers MT, Jhingran A. Uterine sarcomas. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag: New York, 125-147, 2006.
13. Ramondetta LM, Burke TW, Broaddus R, Jhingran A. Treatment of endometrial cancer. In: Gynecologic Cancer, MD Anderson Cancer Care Series. Springer-Verlag: New York, 148-174, 2006.
14. Brown J, Jhingran A, Deavers M, Markman M.. Stromal tumors of the ovary. In: Textbook of Uncommon Cancer. 3rd. John Wiley and Sons, Ltd: West Sussex UK, 455-466, 2006.
15. Jhingran A, Eifel PJ, Wharton JT, Totolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine. 7th. BC Decker Inc: Hamilton, London, 1497-1521, 2006.
16. Jhingran A, Salehpour M, Brooks B. Endometrial cancer. In: Intensity Modulated Radiation Therapy: A Clinical Perspective. BC Decker: Philadelphia, 513-517, 2005.
17. Jhingran A. Gynecologic cancers. In: Practical Essential of Intensity Modulated Radiation Therap. Lippincott Williams and Wilkins: Philadelphia, 325-351, 2005.
18. Jhingran A, Eifel PJ. Cancer of the endometrium. In: Radiation Oncology. 8th. Mosby: St. Louis MO, 724-742, 2003.
19. Jhingran A, Eifel PJ, Wharton JT, Tortolero-Luna G. Neoplasms of the cervix. In: Cancer Medicine. 6th. B. C. Decker, Inc: Ontario, 1779-1808, 2003.
20. Jhingran A, Eifel PJ. Radiation therapy. In: Handbook of Gynecologic Oncology. Martin Dunitz Ltd: London, 77-90, 2002.
21. Jhingran A, Eifel PJ. Radiation therapy for invasive cervical cancer. In: ACS Atlas of Oncology: Cervix, Vulva and Vagina. B. C. Decker, Inc: Ontario, 147-168, 2001.
22. Jhingran A, Eifel PJ. The role of radiotherapy in the management of vulvar cancer. In: Cancer and Precancer of the Vulva. Thomson Science & Professional: London, 120-134, 2000.
23. Jhingran A, Eifel PJ. Radiotherapy. In: Gynecologic Oncology Handbook. Martin Dunitz Ltd: London, 73-87, 2000.